Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New model of prostate cancer helps identify promising pain treatment

02.12.2005


Researchers have developed a new line of prostate cancer cells that they hope will provide a better model to study the disease.



This new cancer-cell line has already provided some help. One new study in mice identified a promising possible therapy to reduce skeletal pain that accompanies prostate cancer. Scientists found that a substance called anti-nerve growth factor appeared to be more effective in controlling pain in mice than even morphine.

But the work would not have been possible without the new cell line, said Tom Rosol , a study co-author and a professor of veterinary medicine at Ohio State University.


Armed with this new cell line, scientists will be able to more directly study how prostate cancer affects the body, said Rosol, whose laboratory developed the cell line.

Metastatic bone tumors are a common manifestation in patients with late-stage breast cancer or prostate cancer. “Metastasis” means that cancer has spread from its original site to other areas of the body. But breast cancer typically destroys bone at tumor sites, whereas prostate cancer tumors that spread to bone induce abnormal bone growth.

Currently, most models used to study prostate cancer do not mimic the human condition and the resulting bone metastases. Most of these models really mimic the spread of breast cancer since the bone metastases in that disease are associated with bone loss rather than bone growth.

“Even though there is more bone at the sites of prostate cancer tumors, this formation still damages the bone,” said Rosol, who is also dean of the College of Veterinary Medicine at Ohio State . “The new growth compresses nerves, making it terribly painful for the patient.”

The results appear in a recent issue of the journal Cancer Research. The study was led by Patrick Mantyh, a professor of preventive sciences at the University of Minnesota.

Only two mammals are known to develop prostate cancer –- men and dogs. Rosol’s laboratory created a cell line from prostate tumors that had developed in a dog’s bones. The researchers call this line of cells ACE-1.

In the current study, researchers at the University of Minnesota injected the ACE-1 cells directly into the femurs, or thigh bones, of male mice. These mice were specially bred to lack an immune system, leaving them vulnerable to developing prostate cancer. While the femur is the biggest bone in the body -- and therefore the easiest to study in this case -- prostate cancer can affect any bone in the body.

It took about a week for the prostate tumors to develop in the mice. At that point, the researchers began treating mice with anti-nerve growth factor (NGF). Anti-NGF is a molecule that naturally occurs in the body, where it promotes the survival and growth of nerves. An additional group of mice was treated with morphine. Control mice, which also had prostate cancer, were given a sterile saline solution instead of either anti-NGF or morphine.

The researchers wanted to know what kind of effect, if any, anti-NGF had on pain-related behaviors, tumor growth, bone formation and bone destruction in the mice.

The researchers watched mice at different points in the study to see if they showed any kind of pain-related behavior. The researchers kept track of how much time each mouse spent favoring its affected leg – how often the mouse lifted its leg while standing still, and for how long it held this leg aloft.

Mice treated with anti-NGF spent less time favoring their affected leg than did mice that were given morphine. In some cases, the time that a mouse treated with anti-NGF spent favoring its affected leg was half that of a mouse treated with morphine.

This suggests that anti-NGF therapy may be effective in reducing pain, thereby helping to enhance the quality of life in patients with bone pain caused by prostate cancer.

All of the animals were euthanized about two weeks after receiving the first round of ACE-1 injections. At that point, the researchers removed the affected thigh bone from each mouse in order to analyze the bone’s density. Bone density corresponded with the number of tumors in the bone – the denser the bone, the more tumors it had.

Results from the density analysis showed that anti-NGF therapy did not stop prostate cancer from progressing, nor did it decrease bone formation caused by the disease.

Why prostate cancer causes excess bone to form remains a mystery, but having the ACE-1 model may help researchers learn why it happens.

“Bone is often the only clinically detectable site of the spread of prostate cancer,” Rosol said. “Understanding why this happens is not only important for cancer patients, but also for scientists who are trying to understand how bone responds to different biochemical factors.”

Rosol conducted the study with researchers from the University of Minnesota; the Veterans Affairs Medical Center in Minneapolis; and with Rinat Neuroscience Corporation, in Palo Alto, Calif.

This work was supported by a grant from the National Institutes of Health, the MinCREST program at the University of Minnesota and a Merit Review from the Veterans Administration.

Thomas Rosol | EurekAlert!
Further information:
http://www.ohio-state.edu

More articles from Life Sciences:

nachricht New risk factors for anxiety disorders
24.02.2017 | Julius-Maximilians-Universität Würzburg

nachricht Stingless bees have their nests protected by soldiers
24.02.2017 | Johannes Gutenberg-Universität Mainz

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

Im Focus: Mimicking nature's cellular architectures via 3-D printing

Research offers new level of control over the structure of 3-D printed materials

Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...

Im Focus: Three Magnetic States for Each Hole

Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".

Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

Stingless bees have their nests protected by soldiers

24.02.2017 | Life Sciences

New risk factors for anxiety disorders

24.02.2017 | Life Sciences

MWC 2017: 5G Capital Berlin

24.02.2017 | Trade Fair News

VideoLinks
B2B-VideoLinks
More VideoLinks >>>